PCSK-9: Entering a new era of cardiovascular risk prediction

Int J Cardiol. 2018 Jul 15:263:152-153. doi: 10.1016/j.ijcard.2018.03.138.

Authors

Thomas H Schindler¹, Thorsten M Leucker²

Affiliations

¹ Mallinckrodt Institute of Radiology, Division of Nuclear Medicine, Cardiovascular Medicine, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: thschindler@wustl.edu.
² Department of Medicine, Division of Cardiology, Johns Hopkins University, Baltimore, MD, USA.

PMID: 29754911
DOI: 10.1016/j.ijcard.2018.03.138

No abstract available

Keywords: Arterial plaque; Atherosclerosis; Cardiovascular events; Carotid stenosis; LDL cholesterol; Outcome; PCSK9; Prognosis.

Publication types

Editorial
Comment

MeSH terms

Cardiovascular Diseases*
Cholesterol, LDL
Humans
Proprotein Convertase 9*
Proprotein Convertases
Risk Factors

Substances

Cholesterol, LDL
Proprotein Convertase 9
Proprotein Convertases